Tag

#dividend-stocks

Jul 2, 2026

AstraZeneca (AZN) stock: bull, base, bear case to 2031

AZN stock forecast: bull, base, bear scenarios across 6 months, 1yr, 3yr, and 5yr. Oncology growth vs Tagrisso patent cliff, IRA pricing, pending China risk.

Jul 2, 2026

Merck (MRK) stock: bull, base, and bear case from 6 months to 5 years

Merck (MRK) forecast: bull, base, bear scenarios across 6 months to 5 years. Keytruda's 2028 patent cliff and IRA pricing vs. the pipeline; Hold rating, Undervalued.

Jul 2, 2026

MUFG stock: the 6-month to 5-year bull, base, and bear case

MUFG research: bear/base/bull scenarios across 6 months, 1 year, 3 years, and 5 years, plus the BoJ rate tailwind, the falling CET1 ratio, and the Morgan Stanley stake

Jul 2, 2026

Novartis (NVS) stock: bull, base, and bear case from 6 months to 5 years

Novartis (NVS) forecast with bull, base, bear scenarios across 6 months, 1 year, 3 years, and 5 years. Five growth brands vs. the Entresto and Cosentyx patent cliffs; Buy rating, Undervalued.

Jul 2, 2026

Rio Tinto (RIO) stock forecast: a Hold as copper offsets iron ore

Rio Tinto stock forecast across 6 months to 5 years with bear, base, and bull price scenarios. Copper growth at Oyu Tolgoi offsets iron ore headwind. Hold at fair value.

Jul 2, 2026

Royal Bank of Canada (RY): 6-Month to 5-Year Stock Outlook

Deep research on RY: bear, base, and bull scenarios across 6 months, 1 year, 3 years, and 5 years, plus the Q2 FY2026 earnings and mortgage-renewal-wall risk.

Jun 30, 2026

AbbVie (ABBV) stock: bull, base, and bear case from 6 months to 5 years

AbbVie (ABBV) forecast with bull, base, bear scenarios across 6 months, 1 year, 3 years, and 5 years. Skyrizi-Rinvoq growth vs. IRA drug pricing and patent cliff; Buy rating, Fair valuation.

Jun 30, 2026

HSBC Holdings: Asia-wealth re-rating made, buyback paused, double-hit risk

HSBC trades at 2.0x tangible book on 17%+ RoTE Asia-wealth franchise, but buyback paused and rate cuts plus China/Hong Kong credit deterioration risk unwinding re-rating.

Jun 30, 2026

Procter & Gamble stock: 21x forward, Dividend King, Hold (bull/base/bear to 2031)

PG at 21x forward: Hold. Dividend King with margin pressure. Bull/base/bear scenarios: 6 months, 1 year, 3 years, and 5 years.